BusinessHeart Recovery Patients Visit Capitol Hill to Advocate for Lifesaving Cardiovascular TechnologyBy Nasdaq OMXJun 9, 2017, 12:08 PM UTC
BusinessARCA Biopharma Announces First Quarter 2017 Financial Results and Provides Business UpdateBy Nasdaq OMXMay 15, 2017, 12:32 PM UTC
BusinessARCA Biopharma Announces First Quarter 2017 Financial Results and Provides Business UpdateBy Nasdaq OMXMay 15, 2017, 12:32 PM UTC
BusinessARCA Biopharma Announces First Quarter 2017 Financial Results and Provides Business UpdateBy Nasdaq OMXMay 15, 2017, 12:32 PM UTC
BusinessAbiomed Introduces 3rd Generation Impella CP® Heart Pumps at SCAI 2017By Nasdaq OMXMay 9, 2017, 1:34 PM UTC
BusinessHealth in Code’s Novel Work Published In JACC, Helps Increase Sensitivity Detection for Admera Health’s CardioGxOne™ Test Regarding Patients with High-Risk Dilated and Arrhythmogenic CardiomyopathiesBy Nasdaq OMXMay 3, 2017, 1:13 PM UTC
BusinessFirst-Ever Presentation on Abiomed’s Impella® Quality (IQ) Assurance Program and Importance of Treatment Protocols to Improve Patient Survival and Heart Recovery at the 2017 American College of Cardiology Scientific SessionBy Nasdaq OMXMar 19, 2017, 6:30 PM UTC
BusinessAbiomed's Impella® Technology Showcased at 2017 American College of Cardiology Scientific Session With More Than 10 PresentationsBy Nasdaq OMXMar 16, 2017, 12:00 PM UTC
